+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5311178
  • Report
  • April 2022
  • Region: Global
  • 197 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • ApoCell, Inc.
  • BIOCEPT, INC.
  • Bio-Techne Corporation
  • Epic Sciences
  • IVDiagnostics
  • Precision for Medicine
The Global Circulating Tumor Cell Market size was estimated at USD 9,614.20 million in 2021, USD 10,932.26 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.88% to reach USD 20,977.18 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Circulating Tumor Cell to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Specimen, the market was studied across Blood, Bone Marrow, and Other Body Fluids.
  • Based on Technology, the market was studied across CTC Analysis, CTC Detection & Enrichment Methods, and CTC Direct Detection Methods. The CTC Detection & Enrichment Methods is further studied across Combined Methods, Density-based Separation, Immunocapture, and Size-based Separation. The Immunocapture is further studied across Negative Selection and Positive Selection. The Size-based Separation is further studied across Membrane-based and Microfluidic-based.
  • Based on Product, the market was studied across Blood Collection Tubes, Devices or Systems, and Kits & Reagents.
  • Based on Application, the market was studied across Clinical/ Liquid Biopsy and Research. The Clinical/ Liquid Biopsy is further studied across Risk Assessment and Screening and Monitoring. The Research is further studied across Cancer Stem Cell & Tumorigenesis Research and Drug/Therapy Development.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Circulating Tumor Cell market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Circulating Tumor Cell Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Circulating Tumor Cell Market, including Advanced Cell Diagnostics, Inc., ApoCell, Inc., Aviva Biosciences, Bio-Techne Corporation, BioCep Ltd., BIOCEPT, INC., BioFluidica, Biolidics Limited, Canopus Bioscience Ltd., Creatv MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., IVDiagnostics, LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, NanoString Technologies, Inc., Precision for Medicine, QIAGEN, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, and Vitatex, Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Circulating Tumor Cell Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Circulating Tumor Cell Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Circulating Tumor Cell Market?
4. What is the competitive strategic window for opportunities in the Global Circulating Tumor Cell Market?
5. What are the technology trends and regulatory frameworks in the Global Circulating Tumor Cell Market?
6. What is the market share of the leading vendors in the Global Circulating Tumor Cell Market?
7. What modes and strategic moves are considered suitable for entering the Global Circulating Tumor Cell Market?
Frequently Asked Questions about the Global Circulating Tumor Cell Market

What is the estimated value of the Global Circulating Tumor Cell Market?

The Global Circulating Tumor Cell Market was estimated to be valued at $9614.2 Million in 2021.

What is the growth rate of the Global Circulating Tumor Cell Market?

The growth rate of the Global Circulating Tumor Cell Market is 13.8%, with an estimated value of $20977.2 Million by 2027.

What is the forecasted size of the Global Circulating Tumor Cell Market?

The Global Circulating Tumor Cell Market is estimated to be worth $20977.2 Million by 2027.

Who are the key companies in the Global Circulating Tumor Cell Market?

Key companies in the Global Circulating Tumor Cell Market include Advanced Cell Diagnostics, Inc., ApoCell, Inc., Aviva Biosciences, Bio, Techne Corporation, BioCep Ltd., BIOCEPT, INC., BioFluidica and Canopus Bioscience Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ApoCell, Inc.
  • BIOCEPT, INC.
  • Bio-Techne Corporation
  • Epic Sciences
  • IVDiagnostics
  • Precision for Medicine

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased spending in cancer-related therapies
5.1.1.2. Growing prevalence of cancer across the globe
5.1.2. Restraints
5.1.2.1. Lack of awareness about CTC therapeutics
5.1.3. Opportunities
5.1.3.1. Technological advancements in bioengineering and biomedical practices
5.1.3.2. Demand for minimally invasive diagnostics in recent years
5.1.4. Challenges
5.1.4.1. Stringent government regulations for the approval of CTC technologies
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Circulating Tumor Cell Market, by Specimen
6.1. Introduction
6.2. Blood
6.3. Bone Marrow
6.4. Other Body Fluids
7. Circulating Tumor Cell Market, by Technology
7.1. Introduction
7.2. CTC Analysis
7.3. CTC Detection & Enrichment Methods
7.3.1. Combined Methods
7.3.2. Density-based Separation
7.3.3. Immunocapture
7.3.3.1. Negative Selection
7.3.3.2. Positive Selection
7.3.4. Size-based Separation
7.3.4.1. Membrane-based
7.3.4.2. Microfluidic-based
7.4. CTC Direct Detection Methods
8. Circulating Tumor Cell Market, by Product
8.1. Introduction
8.2. Blood Collection Tubes
8.3. Devices or Systems
8.4. Kits & Reagents
9. Circulating Tumor Cell Market, by Application
9.1. Introduction
9.2. Clinical/ Liquid Biopsy
9.2.1. Risk Assessment
9.2.2. Screening and Monitoring
9.3. Research
9.3.1. Cancer Stem Cell & Tumorigenesis Research
9.3.2. Drug/Therapy Development
10. Americas Circulating Tumor Cell Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Circulating Tumor Cell Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Circulating Tumor Cell Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Advanced Cell Diagnostics, Inc.
14.2. ApoCell, Inc.
14.3. Aviva Biosciences
14.4. Bio-Techne Corporation
14.5. BioCep Ltd.
14.6. BIOCEPT, INC.
14.7. BioFluidica
14.8. Biolidics Limited
14.9. Canopus Bioscience Ltd.
14.10. Creatv MicroTech, Inc.
14.11. Epic Sciences
14.12. Fluxion Biosciences, Inc.
14.13. Greiner Bio One International GmbH
14.14. Ikonisys Inc.
14.15. IVDiagnostics
14.16. LungLife AI, Inc.
14.17. Menarini Silicon Biosystems
14.18. Miltenyi Biotec
14.19. NanoString Technologies, Inc.
14.20. Precision for Medicine
14.21. QIAGEN
14.22. Rarecells Diagnostics
14.23. ScreenCell
14.24. STEMCELL Technologies, Inc.
14.25. Sysmex Corporation
14.26. Vitatex, Inc
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CIRCULATING TUMOR CELL MARKET: DYNAMICS
FIGURE 2. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2027
FIGURE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, 2019-2027 (USD MILLION)
FIGURE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 37. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2027
FIGURE 39. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, 2019-2027 (USD MILLION)
FIGURE 40. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, 2019-2027 (USD MILLION)
FIGURE 42. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, 2019-2027 (USD MILLION)
FIGURE 44. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 45. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 46. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2027
FIGURE 48. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2019-2027 (USD MILLION)
FIGURE 49. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 50. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, 2019-2027 (USD MILLION)
FIGURE 51. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 52. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, 2019-2027 (USD MILLION)
FIGURE 53. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2019-2027 (USD MILLION)
FIGURE 55. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 56. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, 2019-2027 (USD MILLION)
FIGURE 57. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 58. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, 2019-2027 (USD MILLION)
FIGURE 59. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 60. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. CANADA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. CHINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. INDIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. ITALY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. QATAR CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. GLOBAL CIRCULATING TUMOR CELL MARKET: FPNV POSITIONING MATRIX
FIGURE 91. GLOBAL CIRCULATING TUMOR CELL MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CIRCULATING TUMOR CELL MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CIRCULATING TUMOR CELL MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 15. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY OTHER BODY FLUIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 36. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2019-2027 (USD MILLION)
TABLE 41. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 46. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY STATE, 2019-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY STATE, 2019-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 65. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2019-2027 (USD MILLION)
TABLE 66. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY STATE, 2019-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 70. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY STATE, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 76. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2019-2027 (USD MILLION)
TABLE 77. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY STATE, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 89. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 91. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 92. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2019-2027 (USD MILLION)
TABLE 93. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 94. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY STATE, 2019-2027 (USD MILLION)
TABLE 95. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 97. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 98. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 99. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 102. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY REGION, 2019-2027 (USD MILLION)
TABLE 103. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 104. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY STATE, 2019-2027 (USD MILLION)
TABLE 105. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING AND MONITORING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 107. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 108. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 109. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 110. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 112. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2019-2027 (USD MILLION)
TABLE 113. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 114. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY STATE, 2019-2027 (USD MILLION)
TABLE 115. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 117. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 118. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 120. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG/THERAPY DEVELOPMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 122. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 123. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. CANADA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 127. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. CHINA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. INDIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 135. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. ITALY CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. QATAR CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 147. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. GLOBAL CIRCULATING TUMOR CELL MARKET: SCORES
TABLE 153. GLOBAL CIRCULATING TUMOR CELL MARKET: BUSINESS STRATEGY
TABLE 154. GLOBAL CIRCULATING TUMOR CELL MARKET: PRODUCT SATISFACTION
TABLE 155. GLOBAL CIRCULATING TUMOR CELL MARKET: RANKING
TABLE 156. GLOBAL CIRCULATING TUMOR CELL MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 157. GLOBAL CIRCULATING TUMOR CELL MARKET: MERGER & ACQUISITION
TABLE 158. GLOBAL CIRCULATING TUMOR CELL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 159. GLOBAL CIRCULATING TUMOR CELL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 160. GLOBAL CIRCULATING TUMOR CELL MARKET: INVESTMENT & FUNDING
TABLE 161. GLOBAL CIRCULATING TUMOR CELL MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 162. GLOBAL CIRCULATING TUMOR CELL MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Advanced Cell Diagnostics, Inc.
  • ApoCell, Inc.
  • Aviva Biosciences
  • Bio-Techne Corporation
  • BioCep Ltd.
  • BIOCEPT, INC.
  • BioFluidica
  • Biolidics Limited
  • Canopus Bioscience Ltd.
  • Creatv MicroTech, Inc.
  • Epic Sciences
  • Fluxion Biosciences, Inc.
  • Greiner Bio One International GmbH
  • Ikonisys Inc.
  • IVDiagnostics
  • LungLife AI, Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec
  • NanoString Technologies, Inc.
  • Precision for Medicine
  • QIAGEN
  • Rarecells Diagnostics
  • ScreenCell
  • STEMCELL Technologies, Inc.
  • Sysmex Corporation
  • Vitatex, Inc
Note: Product cover images may vary from those shown

Loading
LOADING...